GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+21.62%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$347M
AUM Growth
+$347M
(+64%)
Cap. Flow
+$88.9M
Cap. Flow
% of AUM
25.63%
Top 10 Holdings %
Top 10 Hldgs %
36.85%
Holding
91
New
29
Increased
17
Reduced
15
Closed
14
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$16.3M |
| 2 |
Abbott
ABT
|
$12.7M |
| 3 |
Puma Biotechnology
PBYI
|
$10.1M |
| 4 |
DBVT
DBV Technologies
DBVT
|
$9.08M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$8.06M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11M |
| 2 |
Medtronic
MDT
|
$8.68M |
| 3 |
BLUE
bluebird bio
BLUE
|
$7.46M |
| 4 |
Neurocrine Biosciences
NBIX
|
$5.68M |
| 5 |
CONMED
CNMD
|
$5.21M |
Sector Composition
| 1 | Healthcare | 91.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $18M | 2.92% | 500,000 +50,000 | +11% | +$1.8M |
|
|
2
Zimmer Biomet
ZBH
$21B
| $16.3M | 2.64% | +125,000 | New | +$16.3M |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14.7M | 2.38% | 120,000 +30,000 | +33% | +$3.68M |
|
|
NUVA
4
DELISTED
NuVasive, Inc.
NUVA
| $14M | 2.27% | 210,000 +60,000 | +40% | +$4M |
|
|
5
Abbott
ABT
$231B
| $12.7M | 2.06% | +300,000 | New | +$12.7M |
|
|
SPNC
6
DELISTED
Spectranetics Corp
SPNC
| $10.9M | 1.77% | 435,000 +60,000 | +16% | +$1.51M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $10.5M | 1.7% | 100,000 +75,000 | +300% | +$7.84M |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $10.4M | 1.69% | 425,000 +175,000 | +70% | +$4.29M |
|
9
Edwards Lifesciences
EW
$47.8B
| $10.2M | 1.66% | 85,000 | – | – |
|
|
10
Puma Biotechnology
PBYI
$254M
| $10.1M | 1.63% | +150,000 | New | +$10.1M |
|
11
Boston Scientific
BSX
$156B
| $9.52M | 1.54% | 400,000 +75,000 | +23% | +$1.79M |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $9.21M | 1.49% | 150,000 -50,000 | -25% | -$3.07M |
|
|
DBVT
13
DBV Technologies
DBVT
$264M
| $9.08M | 1.47% | +250,000 | New | +$9.08M |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $8.06M | 1.31% | +175,000 | New | +$8.06M |
|
15
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.94M | 1.29% | 1,800,000 +100,000 | +6% | +$441K |
|
|
CYNO
16
DELISTED
Cynosure, Inc. Class A
CYNO
| $7.64M | 1.24% | +150,000 | New | +$7.64M |
|
|
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
| $7.49M | 1.22% | 375,000 +125,000 | +50% | +$2.5M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $7.13M | 1.16% | 575,000 +225,000 | +64% | +$2.79M |
|
19
Iovance Biotherapeutics
IOVA
$807M
| $6.79M | 1.1% | 825,000 +125,000 | +18% | +$1.03M |
|
20
Pacific Biosciences
PACB
$393M
| $6.72M | 1.09% | +750,000 | New | +$6.72M |
|
21
Enanta Pharmaceuticals
ENTA
$180M
| $6.65M | 1.08% | +250,000 | New | +$6.65M |
|
|
IMMU
22
DELISTED
Immunomedics Inc
IMMU
| $6.5M | 1.05% | 2,000,000 +1,000,000 | +100% | +$3.25M |
|
23
Acadia Pharmaceuticals
ACAD
$4.38B
| $6.36M | 1.03% | +200,000 | New | +$6.36M |
|
|
NVRO
24
DELISTED
NEVRO CORP.
NVRO
| $6.26M | 1.02% | 60,000 -20,000 | -25% | -$2.09M |
|
|
SIOX
25
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.6M | 0.91% | 400,000 -175,000 | -30% | -$2.45M |
|